IP Library Granted Patent US 9,468,727
Granted Patent B2
US 9,468,727 · App. 14/094,250 · Granted Oct 18, 2016

Nasal delivery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,468,727
App. No.
14/094,250
Granted
Oct 18, 2016
Kind
B2
Abstract

A nasal delivery device for and a method of delivering a substance to a nasal cavity of a subject, the delivery device comprising: a delivery unit for delivering a flow entraining a substance to one nostril of a subject, the delivery unit including a nosepiece for fitting to a nostril of the subject; and a flow resistor unit for fitting to the other nostril of the subject, the flow resistor unit including a progressive resistor for progressively providing an increasing flow resistance to the delivered flow.

Claims (22)

1. A nasal delivery device for delivering a substance to a nostril of a subject, including:

a nosepiece configured for fitting to a first nostril of the subject, the nosepiece comprising an inlet and an outlet;

a mouthpiece through which the subject in use exhales; and

a flow channel fluidly connecting the nosepiece and the mouthpiece, whereby exhaled air from an exhalation breath is delivered from the mouthpiece to the inlet, through the nosepiece, and out the outlet;

a flow resistor disposed downstream of the mouthpiece and upstream of the outlet of the nosepiece to provide a predeterminable flow resistance to a delivered flow of exhalation breath.

2. The delivery device of claim 1 , wherein the flow resistor is a progressive resistor for progressively providing an increasing flow resistance to the delivered flow.

3. The delivery device of claim 1 , wherein the flow resistor is a fixed resistor for providing a predeterminable resistance to the delivered flow.

4. The delivery device of claim 1 , further including:

a substance supply unit which is actuatable to supply a substance.

5. The delivery device of claim 4 , wherein the substance supply unit is configured to be actuatable to supply a substance at a predeterminable pressure.

6. The delivery device of claim 4 , wherein the substance supply unit is configured to be actuatable to supply a substance at a predeterminable flow rate.

7. The delivery device of claim 4 , wherein the substance supply unit is configured to be actuatable to supply a substance at one or both of a predeterminable pressure and a predeterminable flow rate.

8. The delivery device of claim 4 , wherein the substance supply unit includes a dosing unit for supplying a substance.

9. The delivery device of claim 8 , wherein the dosing unit comprises a nebulizer for supplying an aerosol.

10. The delivery device of claim 8 , wherein the dosing unit comprises an aerosol canister for supplying an aerosol.

11. The delivery device of claim 8 , wherein the dosing unit comprises a delivery pump unit for supplying an aerosol.

12. The delivery device of claim 11 , wherein the delivery pump comprises a liquid pump unit for supplying a liquid aerosol.

13. The delivery device of claim 11 , wherein the delivery pump a powder pump unit for supplying a powder aerosol.

14. The delivery device of claim 8 , wherein the dosing unit comprises a powder delivery unit for delivering a powder aerosol.

15. The delivery device of claim 1 , further including:

a gas flow channel fluidly connected to the nosepiece through which a gas flow, separate from an exhalation breath of a subject, is in use delivered; and

a gas supply unit for supplying a gas flow to the gas flow channel.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069826/0047 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 Recorded Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
SECURITY INTEREST Recorded Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 042704/0995 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2014
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 032440/0995 →